RyanFPorterMD

PubMed

• 19 citations
  Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...
  Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Syed F Zafar, Jamal Misleh, Edwin C Kingsley, Habte A Yimer, Benjamin Freeman, Subramanya S Rao...> ;The Lancet. Haematology. 2023 Jan 1
• 30 citations
  A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.
  Olumide B. Gbolahan, Ryan F. Porter, John T. Salter, Constantin T. Yiannoutsos, Matthew Burns, E. Gabriella Chiorean, Patrick J. Loehrer> ;Journal of Thoracic Oncology. 2018 Dec 1
• 37 citations
  A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.
  Milan Radovich, Jeffrey P. Solzak, Bradley A. Hancock, Madison Conces, Rutuja Atale, Ryan F. Porter, Jin Zhu, Jarret Glasscock, Kenneth A. Kesler, Sunil Badve, Bryan P...> ;British Journal of Cancer. 2016 Feb 16
• 25 citations
  Fragmented esophageal smooth muscle contraction segments on high resolution manometry: a marker of esophageal hypomotility.
  R. F. Porter, Nitin Kumar, Jesse Drapekin, Chandra Prakash Gyawali> ;Neurogastroenterology and Motility. 2012 Aug 1
• 28 citations
  Analysis of intersegmental trough and proximal latency of smooth muscle contraction using high-resolution esophageal manometry.
  Nitin Kumar, Ryan Porter, Jake M. Chanin, C. Prakash Gyawali> ;Journal of Clinical Gastroenterology. 2012 May 1
• Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation.
  Porter, R. F.,Gyawali, C. P.> ;Neurogastroenterol. Motil.. 2010 Oct 14
• Join now to see all